Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Sweet Warning: Mucin-Type O-Glycans in Cancer. | Cells | 2022 | 36429094 | PubTator, text mining | PubMed |
| Comparison of two outside-in transobturator midurethral slings in the treatment of female urodynamic stress incontinence. | Taiwan J Obstet Gynecol | 2022 | 36427964 | PubTator, text mining | PubMed |
| Differential Expression of Serum Proteins in Chronic Obstructive Pulmonary Disease Assessed Using Label-Free Proteomics and Bioinformatics Analyses. | Int J Chron Obstruct Pulmon Dis | 2022 | 36411774 | PubTator, text mining | PubMed |
| Epidemiological Characteristics and Role of Connexin-43 in Patients of Syndactyly Attending a Tertiary Care Center in Odisha, India. | Cureus | 2022 | 36407278 | PubTator, text mining | PubMed |
| The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. | Front Immunol | 2022 | 36405727 | PubTator, text mining | PubMed |
| Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go. | Front Oncol | 2022 | 36387149 | PubTator, text mining | PubMed |
| Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function. | J Med Chem | 2022 | 36382923 | PubTator, text mining | PubMed |
| Changes in Biogenic Amines of Two Table Grapes (cv. Bronx Seedless and Italia) during Berry Development and Ripening. | Plants (Basel) | 2022 | 36365298 | PubTator, text mining | PubMed |
| The Enigmatic Etiology of Oculo-Auriculo-Vertebral Spectrum (OAVS): An Exploratory Gene Variant Interaction Approach in Candidate Genes. | Life (Basel) | 2022 | 36362878 | PubTator, text mining | PubMed |
| Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile. | Biomedicines | 2022 | 36359251 | PubTator, text mining | PubMed |
| A Semi-quantitative Evaluation of Out-to-Out Agenesis of Posterior Wall in a Dry Human Sacrum in Bangladesh. | Cureus | 2022 | 36349077 | PubTator, text mining | PubMed |
| Short-form development of the specific module of the QLICD-CRF(V2.0) for assessing the quality of life of patients with chronic renal failure. | BMC Med Res Methodol | 2022 | 36348284 | PubTator, text mining | PubMed |
| Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype. | Results Probl Cell Differ | 2022 | 36348114 | PubTator, text mining | PubMed |
| Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection. | Clin Chim Acta | 2022 | 36341812 | PubTator, text mining | PubMed |
| Sex difference in the expression of PD-1 of non-small cell lung cancer. | Front Immunol | 2022 | 36341395 | PubTator, text mining | PubMed |
| Cancer Biomarkers in Liquid Biopsy for Early Detection of Breast Cancer: A Systematic Review. | Clin Med Insights Oncol | 2022 | 36338263 | PubTator, text mining | PubMed |
| A murine model for human early/immature T-cell precursor acute lymphoblastic leukemia (EITP ALL). | Oncoscience | 2022 | 36330381 | PubTator, text mining | PubMed |
| The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients. | Turk J Med Sci | 2022 | 36326416 | PubTator, text mining | PubMed |
| Adding recombinant AAVs to the cancer therapeutics mix. | Mol Ther Oncolytics | 2022 | 36321134 | PubTator, text mining | PubMed |
| Immune checkpoint alterations and their blockade in COVID-19 patients. | Blood Sci | 2022 | 36311817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=19